Annual Report Presentation and Q&A
How does this Q&A work:
This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.
The company will address as many questions as possible, and focus on those questions most wanted by investors.
Speakers at this event:
4 Questions
March 27, 2026
Have you seen evidence that your longevity sales are indeed recurring and not just one-off sales?
March 27, 2026
You mention the “de novo” application for FDA. Earlier you have also mentioned that it could be called 510(k) – what is the difference and why do you no longer say 510(k)?
March 26, 2026
If poc-test is finally testet ok.
When do you then expect launch, - and which market segment Will be adressed?
March 26, 2026
what would it take to increase sales faster ?